We have collected information about Helicobacter Pylori As A Vaccine Delivery System for you. Follow the links to find out details on Helicobacter Pylori As A Vaccine Delivery System.
https://www.ncbi.nlm.nih.gov/pubmed/17991181
1. Helicobacter. 2007 Nov;12 Suppl 2:75-9. Helicobacter pylori as a vaccine delivery system. Marshall B(1), Schoep T. Author information: (1)Helicobacter pylori Research Laboratory, Microbiology and Immunology, University of Western Australia, Perth, Western Australia, Australia. [email protected] For more than 10 years a vaccine against Helicobacter pylori has been the elusive goal of many ...Author: Barry Marshall, Tobias Schoep
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1523-5378.2007.00568.x
Helicobacter pylori as a Vaccine Delivery System Barry Marshall. Helicobacter pylori Research Laboratory, Microbiology and Immunology, University of Western Australia, Perth, Western Australia; ... For more than 10 years a vaccine against Helicobacter pylori has been the elusive goal of many investigators. The need for a vaccine was highlighted ...Author: Barry Marshall, Tobias Schoep
https://www.researchgate.net/publication/5855911_Helicobacter_pylori_as_a_Vaccine_Delivery_System
Helicobacter pylori as a Vaccine Delivery System Article · Literature Review in Helicobacter 12 Suppl 2(s2):75-9 · December 2007 with 46 Reads How we measure 'reads'
https://www.creative-biolabs.com/vaccine/helicobacter-pylori-vaccines.htm
The H. pylori urease B subunit vaccine utilized an efficient nanoparticle system for vaccination to achieve both cargo protection and mucosal penetration. This delivery system is comprised of an anionic, hydrophilic, mercaptosuccinic acid-functionalized poly (ethylene glycol) derivative and the transepithelial penetration was achieved by the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789989/
Mar 21, 2016 · INTRODUCTION. Helicobacter pylori (H. pylori) is one of the most successful human pathogens.Following two important events (first successful isolation of the H. pylori in 1983 and secondly; Nobel Prize in medicine in 2005), increasing attention is focused on the human gastric inhabitant and soon after, everyone was surprised by its globally high prevalence (approximately 50%)[1,2].
https://www.researchgate.net/publication/26864179_Helicobacter_pylori_vaccine_Mucosal_adjuvant_delivery_systems
Helicobacter pylori vaccine: Mucosal adjuvant & delivery systems Article · Literature Review in The Indian Journal of Medical Research 130(2):115-24 · August 2009 with 21 Reads
https://www.sciencedirect.com/science/article/pii/S0264410X01001190
Jul 16, 2001 · The use of Lactococcus lactis as an antigen delivery vehicle for mucosal immunisation has been proposed. To determine whether L.lactis could effectively deliver Helicobacter pylori antigens to the immune system, a recombinant L. lactis expressing H. pylori urease subunit B (UreB) was constructed. Constitutive expression of UreB by a pTREX1 vector resulted in the intracellular accumulation of ...Author: Ming Hsun Lee, Yvonne Roussel, Mark Wilks, Soad Tabaqchali
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-019-0441-y
Jan 19, 2019 · This epitope-loaded nanoemulsion delivery system was shown to extend antigen release and elicit potent Th1 response, it is an applicable delivery system for intranasal vaccine against H. pylori. Helicobacter pylori (H. pylori) infection remains a global public health issue, especially in Asia.Author: Yun Yang, Li Chen, Hong-wu Sun, Hong Guo, Zhen Song, Ying You, Liu-yang Yang, Ya-nan Tong, Ji-ning G...
https://www.advancedsciencenews.com/syringe-free-oral-vaccince-against-heliobacter-pylori/
Jun 25, 2018 · To fight antibiotic-resistant pathogens, and to ensure wide-spread application and high compliance, oral vaccinations are desirable, but pose drug delivery complications. An efficient nanoparticle system for vaccination against stomach ulcer …
https://www.sciencedirect.com/science/article/pii/S0264410X18300173
Preclinical: EpiVax Helicobacter pylori vaccine is an epitope-based vaccine, which involves an initial DNA vaccination followed by a peptide-liposome and which has shown some therapeutic protection in mice .Helicovaxor® has examined two approaches, one involving a non-pathogenic Vibrio cholerae vaccine strain, engineered to express H. pylori antigens (HpaA, UreB and FlaA) , and an inactivated ...Author: Philip Sutton, Joanne M. Boag
Searching for Helicobacter Pylori As A Vaccine Delivery System?
You can just click the links above. The data is collected for you.
